Skip to main content
. 2021 Feb 23;8:608959. doi: 10.3389/fmed.2021.608959

Table 3.

Factors influencing decision to participate in COVID-19 clinical trials.

Would the following statements influence your decision to participate in a COVID-19 clinical trial? No. of “yes” respondents of the total sample (%) (N = 1,576) Attitude toward participating in a clinical trial Rho (P-value) P-value*
Positive (%) (n = 909) Negative (%) (n = 667)
A. Positive factors
Contributing to the protection of my family from COVID-19 encourages me to participate. 1,259 (80.5) 836 (92.4) 423 (64.2) 0.40 (<0.001) ** <0.001
The conduct of clinical trials will be in accordance with the scientific research, and ethical guidelines encourages me to participate. 1,202 (77.1) 825 (91.0) 377 (57.6) 0.45 (<0.001) <0.001
Contributing to the return of normal life encourages me to participate. 1,187 (76.2) 810 (89.6) 377 (57.7) 0.43 (<0.001) <0.001
Contributing to the salvation of humankind from COVID-19 encourages me to participate. 1,169 (74.9) 803 (88.5) 366 (56.0) 0.43 (<0.001) <0.001
Contributing to the protection of my community from COVID-19 encourages me to participate. 1,151 (73.6) 794 (87.7 357 (54.2) 0.44 (<0.001) <0.001
Receiving additional health care benefits encourages me to participate. 850 (54.3) 599 (66.1) 251 (38.1) 0.31 (<0.001) <0.001
Receiving a financial reward encourages me to participate. 323 (20.6) 216 (23.9) 107 (16.2) 0.13 (<0.001) <0.001
B. Negative factors
The probability of occurrence of negative consequences to my health prevents me from participating in such studies. 1,054 (67.4) 528 (58.2) 526 (80.1) −0.33 (<0.001) <0.001
Having limited information about clinical trials, in general, prevents me from participating in such studies. 876 (56.5) 481 (53.3) 395 (61.0) −0.13 (<0.001) 0.003
The possibility that these studies will not be conducted in an ethical manner that follows the required scientific and research methods prevents me from participating in such studies. 849 (54.5) 462 (51.2) 387 (59.1) −0.11 (<0.001) 0.002
The possibility of exploiting me and turning into a “lab rat” prevents me from participating in such studies. 842 (53.9) 416 (45.9) 426 (65.0) −0.24 (<0.001) <0.001
Lack of trust in pharmaceutical companies, in general, prevents me from participating in such studies. 709 (45.5) 364 (40.3) 345 (52.8) −0.17 (<0.001) <0.001
Having limited information about the novel coronavirus and COVID-19 prevents me from participating in such studies. 684 (44.0) 343 (38.0) 341 (52.4) −0.15 (<0.001) <0.001
The possibility of violating my privacy (such as if my samples and health data are sent to other centers and countries) prevents me from participating in such studies. 558 (35.7) 288 (31.8) 270 (41.1) −0.13 (<0.001) <0.001
Having limited time prevents me from participating in such studies. 525 (34.0) 295 (32.9) 230 (35.5) 0.05 (0.06) 0.28
My family's attitude toward participation in these studies prevents me from participating in such studies. 523 (33.7) 277 (30.7) 246 (37.8) −0.09 (<0.001) 0.003
My current medical problems prevent me from participating in such studies. 425 (27.5) 224 (24.9) 201 (30.9) −0.07 (0.008) 0.009
Lack of trust in physicians and hospitals, in general, prevents me from participating in such studies. 424 (27.2) 186 (20.6) 238 (36.4) −0.19 (<0.001) <0.001
Lack of trust in researchers and scientists, in general, prevents me from participating in such studies. 321 (20.7) 142 (15.7) 179 (27.5) −0.15 (<0.001) <0.001
Lack of conviction about the value and benefits of these trials prevents me from participating in such studies. 283 (18.3) 135 (15.0) 148 (22.9) −0.10 (<0.001) <0.001
My religious beliefs toward participation in these studies prevent me from participating in such studies. 156 (10.0) 86 (9.5) 70 (10.7) 0.01 (0.58) 0.46
Customs and traditions in my community prevent me from participating in such studies 151 (9.7) 75 (8.3) 76 (11.7) 0.04 (0.09) 0.03
*

This P-value is based on Chi-square test.

**

Bold values indicate significant P values (<0.05).